Leinamycin (LNM), produced by Streptomyces atroolivaceus, is a thiazole-containing hybrid peptidepolyketide natural product structurally characterized with an unprecedented 1,3-dioxo-1,2-dithiolane moiety that is spiro-fused to a 18-member macrolactam ring. LNM exhibits a broad spectrum of antimicrobial and antitumor activities, most significantly against tumors that are resistant to clinically important anticancer drugs, resulting from its DNA cleavage activity in the presence of a reducing agent. Using a PCR approach to clone a thiazole-forming nonribosomal peptide synthetase (NRPS) as a probe, we localized a 172-kb DNA region from S. atroolivaceus S-140 that harbors the lnm biosynthetic gene cluster. Sequence analysis of 11-kb DNA revealed three genes, lnmG, lnmH, and lnmI, and the deduced product of lnmI is characterized by domains characteristic to both NRPS and polyketide synthase (PKS). The involvement of the cloned gene cluster in LNM biosynthesis was confirmed by disrupting the lnmI gene to generate non-LNM-producing mutants and by characterizing LnmI as a hybrid NRPS-PKS megasynthetase, the NRPS module of which specifies for L-Cys and catalyzes thiazole formation. These results have now set the stage for full investigations of LNM biosynthesis and for generation of novel LNM analogs by combinatorial biosynthesis.The five-member heterocycles of thiazole or oxazole or their reduced structures of thiazoline and thiazolidine or oxazoline and oxazolidine are signature pharmacophores common to many clinically important natural products (44), such as bacitracin (26) and pristinamycin II B (4) (antibacterial) and bleomycin (12) and epothilone (35, 49) (anticancer) (Fig. 1A). They are also common structural motifs for many microbial pathogenesis factors (10), such as pyochelin from Pseudomonas aeruginosa (9, 39), vibriobactin from Vibrio cholerae (23, 52), yersiniabactin from Yersinia pestis (17, 40), mycobactin from Mycobacterium tuberculosis (41), and microcin B17 from Escherichia coli (24, 29) (Fig. 1B).Biosynthetically these heterocycles result from cyclization (Cy) of the cysteine (Cys), serine, or threonine side chain onto the proceeding carbonyl group of the peptide substrates, and two mechanisms are known for this process. One is exemplified by the maturation of microcin B17, where the heterocycleforming steps occur posttranslationally, catalyzed by the microcin B17 synthetase (29). The other is observed for nonribosomal peptide biosynthesis where the peptide elongation and heterocycle-forming steps proceed processively, catalyzed by nonribosomal peptide synthetases (NRPS). The latter enzymes are characterized by unique catalytic domains, such as the Cy, oxidization (Ox), and reduction domains, which act on the nascent peptidyl-S-NRPS intermediate to furnish the heterocycles into the resultant natural products (11,27,44,51).Leinamycin (LNM) is a novel thiazole-containing natural product produced by several Streptomyces atroolivaceus species (18,20,36). Its structure was established by spectroscopic (18,...